Myrna Rauckhorst

Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial

Ravi A. Madan, Mahsa Mohebtash, Philip M. Arlen et al. · The Lancet Oncology · 2012 · 327 citations · Full text

Urology, Medicine, Vaccine Target +9

Avelumab for metastatic or locally advanced previously treated solid tumours (JAVELIN Solid Tumor): a phase 1a, multicohort, dose-escalation trial

Christopher R. Heery, Geraldine O’Sullivan Coyne, Ravi A. Madan et al. · The Lancet Oncology · 2017 · 292 citations · Full text

Medicine, Javelin Solid Tumor, Solid Tumours +6

Phase I Trial of a Yeast-Based Therapeutic Cancer Vaccine (GI-6301) Targeting the Transcription Factor Brachyury

Christopher R. Heery, B. Harpreet Singh, Myrna Rauckhorst et al. · Cancer Immunology Research · 2015 · 136 citations · Full text

Immunology, Immunoediting, Pathology +16

A Pilot Study of MUC-1/CEA/TRICOM Poxviral-Based Vaccine in Patients with Metastatic Breast and Ovarian Cancer

Mahsa Mohebtash, Kwong-Yok Tsang, Ravi A. Madan et al. · Clinical Cancer Research · 2011 · 128 citations · Full text

Phase I trial of a recombinant yeast-CEA vaccine (GI-6207) in adults with metastatic CEA-expressing carcinoma

Marijo Bilušić, Christopher R. Heery, Philip M. Arlen et al. · Cancer Immunology Immunotherapy · 2013 · 102 citations · Full text

Vaccination, Medicine, Immunology +8